Pancreatic Cancer
Prompt identification of new-onset diabetes may aid early detection of pancreatic cancer
WASHINGTON — An algorithm that uses electronic health record parameters identified glycemic evidence of new-onset diabetes in real time, which could lead to earlier detection of pancreatic ductal adenocarcinoma, according to researchers.
Findings highlight ‘desperate need’ to improve end-of-life cancer treatment
Oncologic treatment of adults with various metastatic or advanced solid tumors may not improve OS and could be detrimental to quality of life, according to findings published in JAMA Oncology.
Trial to assess novel surgical procedure for locally advanced pancreatic cancer
A clinical trial at Keck Medicine of USC will investigate a new surgical approach to treating patients with locally advanced pancreatic cancer.
Novel blood test shows promising accuracy for detection of early-stage pancreatic cancer
A next-generation biomarker-based blood test demonstrated 98% specificity and 75% sensitivity in detecting stage I and II pancreatic ductal adenocarcinoma, according to a press release from the manufacturer.
Framework identifies yearly screening candidates at high risk for pancreatic cancer
A consortium recommended classifying people with a high risk for pancreatic cancer into subtypes based on family history and germline variants, according to findings published in Journal of the National Comprehensive Cancer Network.
Precision oncology trial to be conducted entirely through telehealth
Researchers are launching an all-telehealth precision oncology trial that will include patients with pancreatic cancer whose tumors have the same genetic mutation.
New blood test close to ‘cracking the code’ on pancreatic cancer early detection
An investigational exosome-based liquid biopsy showed better than 90% accuracy for detecting early-stage pancreatic cancer among U.S.-based participants in a prospective multicenter study.
Scar tissue patterns may help predict pancreatic cancer outcomes, guide treatment
The organization of cells in scar tissue around pancreatic tumors may help predict survival, according to researchers at Stanford Medicine.
FDA approves Onivyde as first-line treatment for metastatic pancreatic cancer
The FDA approved irinotecan liposome as part of a first-line regimen for the treatment of metastatic pancreatic adenocarcinoma.
‘Molecular twin’ platform could expand use of precision medicine in cancer care
Researchers used an artificial intelligence and precision medicine approach that identifies biomarkers that appear superior to standard tests for predicting pancreatic cancer survival, findings in Nature Cancer showed.